Mumbai-based healthtech startup Truemeds secures $20 Mn from Peak XV Partners in Series C funding round.
Truemeds raises the amount through issuing Series C2 compulsory convertible preference shares, planning to use it for business advancement and growth, with a post money valuation over $400 Mn.
The recent funding is in addition to the $44 Mn raised from Accel India VII (Mauritius) Ltd in March, bringing the total Series C funding to $64 Mn.
Founded by Akshat Nayyar and Kunal Wani, Truemeds focuses on providing alternative medicine brands and affordable options, extending to personal care products, vitamins, supplements, and healthcare devices.